These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2859203

  • 21. Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide.
    Twum-Barima Y, Ahmad D, Hamilton JT, Carruthers SG.
    Clin Pharmacol Ther; 1982 Sep; 32(3):289-94. PubMed ID: 6125288
    [Abstract] [Full Text] [Related]

  • 22. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
    Hosohata Y, Hattori K, Shen Y, Okuyama M, Kaneko H, Ohnuki T, Suzuki J, Nagatomo T.
    Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775
    [Abstract] [Full Text] [Related]

  • 23. Effect of beta-blockers on plasma lipids.
    Pasotti C, Zoppi A, Capra A, Rebagliati M, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280
    [Abstract] [Full Text] [Related]

  • 24. Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agents.
    Dayer P, Balant L, Küpfer A, Courvoisier F, Fabre J.
    Eur J Clin Pharmacol; 1983 Aug; 24(6):797-9. PubMed ID: 6136413
    [Abstract] [Full Text] [Related]

  • 25. The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline.
    Doggrell SA, Henderson CJ.
    J Auton Pharmacol; 1998 Oct; 18(5):263-9. PubMed ID: 9831226
    [Abstract] [Full Text] [Related]

  • 26. Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
    Hosohata Y, Sasaki K, Maruyama K, Ohnuki T, Hattori K, Suzuki J, Watanabe K, Nagatomo T.
    Biol Pharm Bull; 1996 Jul; 19(7):932-5. PubMed ID: 8839963
    [Abstract] [Full Text] [Related]

  • 27. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
    Eagles CJ, Kendall MJ.
    Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
    [Abstract] [Full Text] [Related]

  • 28. Effect of oxidative polymorphism (debrisoquine/sparteine type) on hepatic first-pass metabolism of bufuralol.
    Dayer P, Balant L, Kupfer A, Striberni R, Leemann T.
    Eur J Clin Pharmacol; 1985 Mar; 28(3):317-20. PubMed ID: 2861095
    [Abstract] [Full Text] [Related]

  • 29. The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients.
    Ellis ME, Hussain M, Webb AK, Barker NP, Fitzsimons TJ.
    Br J Clin Pharmacol; 1984 Mar; 17 Suppl 1(Suppl 1):59S-64S. PubMed ID: 6743475
    [Abstract] [Full Text] [Related]

  • 30. Duration of action of beta blockers.
    Johansson SR, McCall M, Wilhelmsson C, Vedin JA.
    Clin Pharmacol Ther; 1980 May; 27(5):593-601. PubMed ID: 6102896
    [Abstract] [Full Text] [Related]

  • 31. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W, Spahn H, Köhler H, Ohnhaus EE, Mutschler E.
    Klin Wochenschr; 1982 Nov 15; 60(22):1401-7. PubMed ID: 7176462
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
    Aellig WH.
    Br J Clin Pharmacol; 1985 Jun 15; 19(6):775-81. PubMed ID: 2862891
    [Abstract] [Full Text] [Related]

  • 33. Epinephrine-induced enhancement of sympathetic activity in humans: inhibition by nonselective as well as beta 1-selective beta-adrenoceptor blockade.
    van den Meiracker AH, Man in 't Veld AJ, Boomsma F, Blankestijn PJ, Schalekamp MA.
    J Cardiovasc Pharmacol; 1990 Apr 15; 15(4):610-7. PubMed ID: 1691392
    [Abstract] [Full Text] [Related]

  • 34. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.
    Head A, Maxwell S, Kendall MJ, Eagles C.
    Br J Clin Pharmacol; 1994 Dec 15; 38(6):499-504. PubMed ID: 7888287
    [Abstract] [Full Text] [Related]

  • 35. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
    Dorow P, Schiess W.
    Klin Wochenschr; 1986 Apr 15; 64(8):366-9. PubMed ID: 2871220
    [Abstract] [Full Text] [Related]

  • 36. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D, Juvent M, Niset G, Wathieu M, Degreve M, Bellens R, Poortmans J, Degre S, Fitzsimons TJ, Herchuelz A.
    Br J Clin Pharmacol; 1984 Apr 15; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [Abstract] [Full Text] [Related]

  • 37. Polymorphic metabolism of beta-adrenoceptor antagonists.
    Silas JH, Lennard MS, Tucker GT, Ramsay LE, Woods HF.
    Br J Clin Pharmacol; 1984 Apr 15; 17 Suppl 1(Suppl 1):11S-19S. PubMed ID: 6146335
    [Abstract] [Full Text] [Related]

  • 38. Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol.
    Grevel J.
    J Cardiovasc Pharmacol; 1986 Apr 15; 8 Suppl 6():S16-9. PubMed ID: 2439812
    [Abstract] [Full Text] [Related]

  • 39. Interaction of cimetidine with metoprolol, propranolol, or atenolol.
    Kirch W, Köhler H, Spahn H, Mutschler E.
    Lancet; 1981 Sep 05; 2(8245):531-2. PubMed ID: 6115283
    [No Abstract] [Full Text] [Related]

  • 40. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T, Mitomi A, Tatebe S, Imai S.
    Arzneimittelforschung; 1989 Apr 05; 39(4):454-7. PubMed ID: 2568836
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.